Asia Pacific Preventive Vaccines Market: By Type (Conjugate Vaccines, Inactivated Vaccines, Subunit and Polysaccharide Vaccines, Live Attenuated Vaccines, Messenger RNA (mRNA) Vaccines, Nucleic Acid Vaccines, Viral Vector Vaccines, Recombinant Vaccines, Toxoid Vaccines, Others); Disease Indication (Bacterial Diseases and Viral Diseases); Route of Administration (Intramuscular, Subcutaneous, Oral Administration, Intra Venous, and Others); Patient Group (Adult and Pediatric); End Users (Hospitals, Clinics, Vaccination Centers, Academic & Research Institutes); Country—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024–2032